查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
合同营销机构全球市场规模研究与预测，按服务（个人促销、非个人促销）、最终用途（製药公司、生物製药公司）、区域分析，2022-2029 年
市场调查报告书
商品编码
1262714

合同营销机构全球市场规模研究与预测，按服务（个人促销、非个人促销）、最终用途（製药公司、生物製药公司）、区域分析，2022-2029 年

Global Pharmaceutical Contract Sales Organizations Market Size study & Forecast, by Service (Personal Promotion, Non-personal Promotion), by End-use (Pharmaceutical Companies, Biopharmaceutical Companies) and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2021 年全球合同销售代理市场价值约为 79 亿美元，预计在 2022-2029 年预测期内将以超过 8.4% 的健康增长率增长。

製药行业已受到审查，以扩大疫苗接种和其他有效治疗替代品的生产能力。 合同销售组织 (CSO) 领域的市场参与者正在使用这些进步来满足消费者和医疗机构的需求。 合同药品销售 (CSO) 领域市场参与者的另一个主要收入驱动因素是增加对免疫系统潜力的了解。 对降低自销成本的需求不断增加、药物研发活动增加以及新药上市数量的增加是行业扩张的一些关键驱动因素。 此外，在 2022-2029 年的预测期内，政府的积极举措和不断增加的老年人口为市场创造了有利可图的增长机会。

生产生物製药的公司目前正专注于加强他们的研究能力。 根据 Pharma R&D 年度回顾，到 2022 年，近 45% 的在研药物将是生物製药。 由于对研究的高度兴趣，生物製药公司有望将其商业活动外包给 CSO，并专注于他们的研究能力。 然而，医药合同销售机构的高成本将阻碍整个 2022-2029 年预测期内的市场增长。

全球合同营销代理市场研究考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 2022年，北美市场份额最大，约占全球行业收入的34.45%。 该地区增长的主要驱动力之一是大量 CSO 的存在，包括 IQVIA, Inc.、EPS Corp. 和 Axxelus。 该地区对药品销售新技术的接受以及该地区大量新药的推出进一步推动了对製药 CSO 的需求。 预计亚太地区将在预测期内以最快的速度增长。 由于该地区不断开发新疗法的製药和生物製药公司数量众多，因此对 CSO 工作的需求量很大。 与其他新兴市场相比，该地区以较低的成本提供 CSO 服务，预计这将促进 CSO 活动并支持行业市场。

这项研究的目的是揭示近年来各个细分市场和国家/地区的市场规模，并预测未来几年的市场规模。 该报告旨在捕捉被调查国家工业的定性和定量方面的情况。

它还提供了关键方面的详细信息，例如决定市场未来增长的驱动因素和挑战。 此外，它还包含供利益相关者投资的潜在微观市场机会，以及对主要参与者的竞争格局和产品的深入分析。 .

内容

第 1 章执行摘要

  • 市场概况
  • 2019-2029 年各细分市场的全球市场估计和预测
    • 2019-2029 年按地区分列的医药合同销售代理市场
    • 按服务划分的医药合同销售代理市场，2019 年至 2029 年
    • 2019-2029 年按最终用途划分的医药合同销售代理市场
  • 主要趋势
  • 调查方法
  • 调查先决条件

第 2 章全球合同营销代理市场的定义和范围

  • 调查目的
  • 市场定义和范围
    • 调查范围
    • 工业发展
  • 本次调查涵盖的年份
  • 货币兑换率

第3章全球合同营销组织的市场动态

  • 合同销售代理市场影响分析（2019-2029）
    • 市场驱动力
      • 重振医药研发活动
      • 不断发展的药物开发
    • 市场挑战
      • 医药寄售组织的高成本结构
    • 市场机会
      • 政府的高度承诺
      • 老年人口增加

第 4 章全球合同营销代理市场行业分析

  • 波特 5 力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係
  • 波特 5 力模型的未来方法 (2019-2029)
  • 害虫分析
    • 政治
    • 经济的
    • 社交
    • 技术
  • 投资招聘模式
  • 分析师的建议和结论
  • 主要投资机会
  • 关键成功策略

第 5 章风险评估：COVID-19 的影响

  • 评估 COVID-19 对行业的总体影响
  • COVID-19 之前和 COVID-19 之后的市场情景

第 6 章全球合同营销代理市场：按服务分类

  • 市场概况
  • 全球合同销售代理市场：按服务、按绩效、潜力分析
  • 2019-2029 年按服务划分的全球合同销售代理市场估计和预测
  • 医药合同销售代理市场，按细分市场分析
    • 个人宣传
    • 非个人宣传

第 7 章全球合同营销代理市场：按最终用途分类

  • 市场概况
  • 全球合同销售代理市场：按最终用途、性能潜力分析
  • 2019-2029 年全球合同销售代理市场的最终用途估计和预测
  • 医药合同销售代理市场，按细分市场分析
    • 製药公司
    • 生物製药公司

第 8 章全球合同营销代理市场：区域分析

  • 医药合同销售代理市场，按地区划分的市场概况
  • 北美
    • 美国
      • 2019-2029 年各服务的估计和预测
      • 2019-2029 年按最终用途估算和预测
    • 加拿大
  • 欧洲合同营销代理市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲
  • 亚太地区合同营销代理市场概况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 拉丁美洲合同营销代理市场概况
    • 巴西
    • 墨西哥
  • 世界其他地方

第 9 章衝突信息

  • 顶级市场策略
  • 公司简介
    • 中民国际控股有限公司
      • 关键信息
      • 概览
      • 财务（仅当数据可用时）
      • 产品概览
      • 近期趋势
    • Axxelus
    • EPS Corp.
    • QFR Solutions
    • MaBico
    • Mednext Pharma Pvt. Ltd.
    • Peak Pharma Solutions Inc.
    • IQVIA, Inc.
    • Promoveo Health
    • Syneous Health

第 10 章研究过程

  • 研究过程
    • 数据挖掘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 调查的特点
  • 调查先决条件

Global Pharmaceutical Contract Sales Organizations Market is valued at approximately USD 7.90 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.4% over the forecast period 2022-2029. In order to expand the production capacity for vaccinations and other efficient treatment alternatives, the pharmaceutical sector has come under scrutiny. These advances are being used by market participants in the pharmaceutical contract sales outsourcing (CSO) sector to meet consumer and healthcare facility demand. Another significant factor generating income prospects for industry participants in the pharmaceutical contract sales outsourcing (CSO) sector is the increased knowledge of the immune system's potential. A rising desire for lower in-house sales costs, a rise in pharmaceutical R&D activities, and a rising number of new medication launches are a few of the major drivers of the industry's expansion. Moreover, high government initiatives and rising geriatric population are creating a lucrative growth opportunity for the market over the forecast period 2022-2029.

Companies that make biopharmaceuticals are currently concentrating on enhancing their research capacities. Almost 45% of all drugs in development in 2022, as per the Pharma R&D annual review, were biopharmaceuticals. It is anticipated that biopharmaceutical companies will outsource their sales activities to CSOs so they may concentrate on their research capabilities due to the great interest these companies have in research. However, the high cost of Pharmaceutical Contract Sales Organizations stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Pharmaceutical Contract Sales Organizations Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2022, North America had the largest market share, accounting for approximately 34.45% of global industry revenue. One of the main factors promoting the region's growth is the existence of a sizable number of CSOs there, including IQVIA, Inc., EPS Corp., and Axxelus. The demand for pharmaceutical CSOs is further supported by the region's embrace of new technology for pharmaceutical sales and a sizable number of new drug launches in the area. During the projected period, the Asia Pacific region is anticipated to increase at the fastest rate. The demand for CSO operations in the region is rising as a result of the substantial number of pharmaceutical and biopharmaceutical businesses in the area that are consistently developing novel treatments. In comparison to other developed areas, the region offers CSO services at a lower cost; this is anticipated to improve CSO activities and assist the sector market.

Major market players included in this report are:

  • CMIC Holdings Co., Ltd.
  • Axxelus
  • EPS Corp.
  • QFR Solutions
  • MaBico
  • Mednext Pharma Pvt. Ltd.
  • Peak Pharma Solutions Inc.
  • IQVIA, Inc.
  • Promoveo Health
  • Syneous Health

Recent Developments in the Market:

  • Dr Reddy's Laboratories and IQVIA, Inc. entered a partnership in September 2022. In accordance with the agreement, IQVIA gave Dr Reddy access to its Orchestrated Customer Engagement (OCE) platform to support its CRM activities. According to the deal, Dr Reddy gave IQVIA's OCE application to all of its marketing users and field staff in India so they could more effectively engage customers by integrating marketing, account management, medical scientific liaison, sales, and other activities.

Global Pharmaceutical Contract Sales Organizations Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Service, End-use, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Service offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Service:

  • Personal Promotion
  • Non-personal Promotion

By End-use:

  • Pharmaceutical Companies
  • Biopharmaceutical Companies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Pharmaceutical Contract Sales Organizations Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Pharmaceutical Contract Sales Organizations Market, by Service, 2019-2029 (USD Billion)
    • 1.2.3. Pharmaceutical Contract Sales Organizations Market, by End-use, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Pharmaceutical Contract Sales Organizations Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Pharmaceutical Contract Sales Organizations Market Dynamics

  • 3.1. Pharmaceutical Contract Sales Organizations Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing pharmaceutical R&D activities
      • 3.1.1.2. Growing drug development
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Pharmaceutical Contract Sales Organizations
    • 3.1.3. Market Opportunities
      • 3.1.3.1. High government initiatives
      • 3.1.3.2. Rising geriatric population

Chapter 4. Global Pharmaceutical Contract Sales Organizations Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Pharmaceutical Contract Sales Organizations Market, by Service

  • 6.1. Market Snapshot
  • 6.2. Global Pharmaceutical Contract Sales Organizations Market by Service, Performance - Potential Analysis
  • 6.3. Global Pharmaceutical Contract Sales Organizations Market Estimates & Forecasts by Service 2019-2029 (USD Billion)
  • 6.4. Pharmaceutical Contract Sales Organizations Market, Sub Segment Analysis
    • 6.4.1. Personal Promotion
    • 6.4.2. Non-personal Promotion

Chapter 7. Global Pharmaceutical Contract Sales Organizations Market, by End-use

  • 7.1. Market Snapshot
  • 7.2. Global Pharmaceutical Contract Sales Organizations Market by End-use, Performance - Potential Analysis
  • 7.3. Global Pharmaceutical Contract Sales Organizations Market Estimates & Forecasts by End-use 2019-2029 (USD Billion)
  • 7.4. Pharmaceutical Contract Sales Organizations Market, Sub Segment Analysis
    • 7.4.1. Pharmaceutical Companies
    • 7.4.2. Biopharmaceutical Companies

Chapter 8. Global Pharmaceutical Contract Sales Organizations Market, Regional Analysis

  • 8.1. Pharmaceutical Contract Sales Organizations Market, Regional Market Snapshot
  • 8.2. North America Pharmaceutical Contract Sales Organizations Market
    • 8.2.1. U.S. Pharmaceutical Contract Sales Organizations Market
      • 8.2.1.1. Service breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. End-use breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Pharmaceutical Contract Sales Organizations Market
  • 8.3. Europe Pharmaceutical Contract Sales Organizations Market Snapshot
    • 8.3.1. U.K. Pharmaceutical Contract Sales Organizations Market
    • 8.3.2. Germany Pharmaceutical Contract Sales Organizations Market
    • 8.3.3. France Pharmaceutical Contract Sales Organizations Market
    • 8.3.4. Spain Pharmaceutical Contract Sales Organizations Market
    • 8.3.5. Italy Pharmaceutical Contract Sales Organizations Market
    • 8.3.6. Rest of Europe Pharmaceutical Contract Sales Organizations Market
  • 8.4. Asia-Pacific Pharmaceutical Contract Sales Organizations Market Snapshot
    • 8.4.1. China Pharmaceutical Contract Sales Organizations Market
    • 8.4.2. India Pharmaceutical Contract Sales Organizations Market
    • 8.4.3. Japan Pharmaceutical Contract Sales Organizations Market
    • 8.4.4. Australia Pharmaceutical Contract Sales Organizations Market
    • 8.4.5. South Korea Pharmaceutical Contract Sales Organizations Market
    • 8.4.6. Rest of Asia Pacific Pharmaceutical Contract Sales Organizations Market
  • 8.5. Latin America Pharmaceutical Contract Sales Organizations Market Snapshot
    • 8.5.1. Brazil Pharmaceutical Contract Sales Organizations Market
    • 8.5.2. Mexico Pharmaceutical Contract Sales Organizations Market
  • 8.6. Rest of The World Pharmaceutical Contract Sales Organizations Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. CMIC Holdings Co., Ltd.
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Axxelus
    • 9.2.3. EPS Corp.
    • 9.2.4. QFR Solutions
    • 9.2.5. MaBico
    • 9.2.6. Mednext Pharma Pvt. Ltd.
    • 9.2.7. Peak Pharma Solutions Inc.
    • 9.2.8. IQVIA, Inc.
    • 9.2.9. Promoveo Health
    • 9.2.10. Syneous Health

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Pharmaceutical Contract Sales Organizations Market, report scope
  • TABLE 2. Global Pharmaceutical Contract Sales Organizations Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Pharmaceutical Contract Sales Organizations Market estimates & forecasts by Service 2019-2029 (USD Billion)
  • TABLE 4. Global Pharmaceutical Contract Sales Organizations Market estimates & forecasts by End-use 2019-2029 (USD Billion)
  • TABLE 5. Global Pharmaceutical Contract Sales Organizations Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Pharmaceutical Contract Sales Organizations Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Pharmaceutical Contract Sales Organizations Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Pharmaceutical Contract Sales Organizations Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Pharmaceutical Contract Sales Organizations Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Pharmaceutical Contract Sales Organizations Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Pharmaceutical Contract Sales Organizations Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Pharmaceutical Contract Sales Organizations Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Pharmaceutical Contract Sales Organizations Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Pharmaceutical Contract Sales Organizations Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Pharmaceutical Contract Sales Organizations Market
  • TABLE 70. List of primary sources, used in the study of global Pharmaceutical Contract Sales Organizations Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Pharmaceutical Contract Sales Organizations Market, research methodology
  • FIG 2. Global Pharmaceutical Contract Sales Organizations Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Pharmaceutical Contract Sales Organizations Market, key trends 2021
  • FIG 5. Global Pharmaceutical Contract Sales Organizations Market, growth prospects 2022-2029
  • FIG 6. Global Pharmaceutical Contract Sales Organizations Market, porters 5 force model
  • FIG 7. Global Pharmaceutical Contract Sales Organizations Market, pest analysis
  • FIG 8. Global Pharmaceutical Contract Sales Organizations Market, value chain analysis
  • FIG 9. Global Pharmaceutical Contract Sales Organizations Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Pharmaceutical Contract Sales Organizations Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Pharmaceutical Contract Sales Organizations Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Pharmaceutical Contract Sales Organizations Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Pharmaceutical Contract Sales Organizations Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Pharmaceutical Contract Sales Organizations Market, regional snapshot 2019 & 2029
  • FIG 15. North America Pharmaceutical Contract Sales Organizations Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Pharmaceutical Contract Sales Organizations Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Pharmaceutical Contract Sales Organizations Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Pharmaceutical Contract Sales Organizations Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Pharmaceutical Contract Sales Organizations Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable